quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 24, 2026

New York Stock Exchange and Securitize Agree to Memorandum of Understanding to Support Tokenized Securities

View original at finance.yahoo.com
New York Stock Exchange and Securitize Agree to Memorandum of Understanding to Support Tokenized Securities Collaboration focuses on digital transfer agent infrastructure and broker-dealer participation to support issuer-sponsored tokenized securities on NYSE’s Digital Trading Platform NEW YORK & MIAMI, March 24, 2026-…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The NYSE continues to lead the industry in responsible innovation

    60% confidence
  • Securitize brings deep experience in digital asset infrastructure and transfer agency, making them a strong partner in helping design this next generation of market structure

    60% confidence
  • The NYSE continues to lead the industry in responsible innovation. As we explore how tokenization can enhance capital markets, it is critical that new infrastructure is developed in a way that preserves the trust, transparency, and protections investors expect.

    60% confidence
  • Securitize has spent years building the regulated infrastructure needed to bring real-world assets on-chain

    60% confidence
  • Securitize has spent years building the regulated infrastructure needed to bring real-world assets on-chain

    60% confidence
  • This is about building tokenization in a way that works within real market structure, with the protections, controls, and operational integrity required for public securities

    60% confidence
  • Building tokenization in a way that works within real market structure requires the protections, controls, and operational integrity required for public securities

    60% confidence
  • This is about building tokenization in a way that works within real market structure, with the protections, controls, and operational integrity required for public securities.

    60% confidence
  • As NYSE explores how tokenization can enhance capital markets, it is critical that new infrastructure is developed in a way that preserves the trust, transparency, and protections investors expect

    60% confidence
  • The NYSE continues to lead the industry in responsible innovation

    60% confidence
  • Securitize brings deep experience in digital asset infrastructure and transfer agency, making them a strong partner in helping design this next generation of market structure

    60% confidence
  • As we explore how tokenization can enhance capital markets, it is critical that new infrastructure is developed in a way that preserves the trust, transparency, and protections investors expect

    60% confidence
  • Securitize has spent years building the regulated infrastructure needed to bring real-world assets on-chain. We are proud to support NYSE in helping design the foundational transfer agent infrastructure for tokenized securities markets.

    60% confidence
  • Securitize brings deep experience in digital asset infrastructure and transfer agency, making them a strong partner in helping design this next generation of market structure.

    60% confidence
  • We are proud to support NYSE in helping design the foundational transfer agent infrastructure for tokenized securities markets

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com